Skip to main content

ESTUDIO DE LOS MECANISMOS PROTECTORES FRENTE AL DESARROLLO DE HIPERTENSION ARTERIAL EN ADULTOS CON SINDROME DE DOWN

PI19/00634

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INVESTIGACION BIOMEDICA HOSPITAL DE LA PRINCESA
Execution centre INSTITUTO DE INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO DE LA PRINCESA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome

  • Sánchez-Moreno, Beatriz|||0000-0002-5182-5745
  • Zhang, Linda
  • Salaberry, Ana Carril
  • Aranha, Mateus|||0000-0001-9594-292X
  • Moldenhauer, Fernando|||0000-0002-6259-8226
  • Brudfors, Mikael
  • Ashburner, John
  • Nachev, Parashkev
  • Real de Asúa, Diego
  • Strange, Bryan A.|||0000-0001-6476-4091
BACKGROUND: To compare the performance of computed tomography (CT) with that of magnetic resonance imaging (MRI) in assessing brain atrophy in Down syndrome (DS). METHODS: Retrospective comparison of CT-derived gray and white matter measurements with those obtained by MRI using voxel-based morphometry (VBM) in adults with DS who underwent both scanning modalities with a maximum interval of 1 year. The concordance of both tests was compared across sample quartiles. RESULTS: Eleven of 23 participants had some degree of cognitive decline. When comparing VBM outputs of both imaging techniques, an overlap of voxels negatively correlated with dementia severity was observed in the right temporal lobe. Observed agreement was 92.3% (quadratic-weighted kappa index 0.71) for both gray and white matter. DISCUSSION: CT and MRI analyses showed a similar decrease in brain volume as cognitive decline increased. Our results highlight the potential use of CT in computational neuroanatomy studies of DS. Highlights: Voxel-based morphometry shows that computed tomography (CT) and magnetic resonance imaging (MRI) yield similar brain atrophy patterns in DS. Strong agreement (kappa index 0.71) was found between CT and MRI assessments. CT-identified right temporal lobe volume loss linked to cognitive decline in DS. CT offers a practical, accessible alternative to MRI for brain imaging in DS. Artificial intelligence-based CT analysis enhances neuroimaging for DS with reduced motion issues.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comparison of covid-19 and non-covid-19 pneumonia in down syndrome

  • Real de Asua, Diego
  • Mayer, Miguel Angel|||0000-0003-0362-6298
  • Del Carmen Ortega, María
  • Borrel, Jose M.
  • de Jesús Bermejo, Teresa
  • González-lamuño, Domingo|||0000-0002-7578-241X
  • Manso, Coral
  • Moldenhauer, Fernando|||0000-0002-6259-8226
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Hüls, Anke|||0000-0002-6005-417X
  • Sherman, Stephanie L.
  • Strydom, Andre
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Dierssen, Mara|||0000-0003-0853-6865
Whether the increased risk for coronavirus disease 2019 (COVID-19) hospitalization and death observed in Down syndrome (DS) are disease specific or also occur in individuals with DS and non-COVID-19 pneumonias is unknown. This retrospective cohort study compared COVID-19 cases in persons with DS hospitalized in Spain reported to the Trisomy 21 Research Society COVID- 19 survey (n = 86) with admissions for non-COVID-19 pneumonias from a retrospective clinical database of the Spanish Ministry of Health (n = 2832 patients). In-hospital mortality rates were significantly higher for COVID-19 patients (26.7% vs. 9.4%), especially among individuals over 40 and patients with obesity, dementia, and/or epilepsy. The mean length of stay of deceased patients with COVID-19 was significantly shorter than in those with non-COVID-19 pneumonias. The rate of admission to an ICU in patients with DS and COVID-19 (4.3%) was significantly lower than that reported for the general population with COVID-19. Our findings confirm that acute SARS-CoV-2 infection leads to higher mortality than non-COVID-19 pneumonias in individuals with DS, especially among adults over 40 and those with specific comorbidities. However, differences in access to respiratory support might also account for some of the heightened mortality of individuals with DS with COVID-19.